Data on the identification of VRK2 as a mediator of PD-1 function

Therapeutic programmed cell death protein 1 (PD-1) blockade enhances T cell mediated anti-tumor immunity, but many patients do not respond, and a significant proportion develops inflammatory toxicities. To develop better therapeutics and to understand the signaling pathways downstream of PD-1 we per...

Descripción completa

Detalles Bibliográficos
Autores principales: Peled, Michael, Adam, Kieran, Mor, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170101/
https://www.ncbi.nlm.nih.gov/pubmed/34113705
http://dx.doi.org/10.1016/j.dib.2021.107168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170101/
https://www.ncbi.nlm.nih.gov/pubmed/34113705
http://dx.doi.org/10.1016/j.dib.2021.107168

Ejemplares similares